CHRISTINA THACKER: Open Payments
NPI 1699225730 · ROOSEVELT, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$583 in 29 payments from 8 companies in 2025. Trend: 2023 $594 · 2024 $612 · 2025 $583
Food & beverage: $583
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $234 |
| Corcept Therapeutics | 5 | $104 |
| AstraZeneca Pharmaceuticals LP | 4 | $82 |
| Exeltis, USA Inc. | 1 | $67 |
| Amgen Inc. | 1 | $38 |
| PFIZER INC. | 2 | $28 |
| Novo Nordisk Inc | 1 | $17 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $14 |
Products named: VRAYLAR, Korlym, TWIRLA, AIRSUPRA, FARXIGA, EVENITY, NURTEC ODT, Rybelsus.
Industry payments across UT — which companies pay providers there.
